和誉医药的“反认知”作战

钛媒体APP
29 May

文 | 氨基观察在港股18A板块,和誉医药可能是过去几年,最颠覆市场认知的存在之一。2024年2月,和誉医药股价创下历史新低2.05港币,市值一度逼近10亿港币。但这样一家“小企业”并没有沉沦,反而依靠ABSK021对外BD带来的价值再发现,上演惊天逆转:最新收盘价8.36港币,市值近60亿港币,让市场直呼意外。并且,和誉医药带给市场的“意外”还未结束。5月25日,和誉医药官宣,依帕戈替尼 (...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10